In Vitro Activity of Telithromycin, Quinupristin/Dalfopristin, Linezolid and Comparator Antimicrobial Agents Against Staphylococcus aureus Clinical Isolates

Authors: Millán, L.; Cerdá, P.; Rubio, M.C.; Gońi, P.; Canales, M.; Capilla, S.; Oca, M.; Gómez-Lus, R.

Source: Journal of Chemotherapy, Number 3, June 2004 , pp. 230-237(8)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

We have studied the prevalence of the different macrolide, lincosamide, streptograminB (MLSB) phenotypes among clinical Staphylococcus aureus isolates erythromycin- and/or oxacillin-resistant; and also the activity of other antimicrobial agents including telithromycin, quinupristin/dalfopristin, linezolid, aminoglycosides, chloramphenicol and vancomycin. We found that 64.86% of S. aureus were oxacillin-resistant. While the most prevalent MLSB phenotype among methicillinresistant S. aureus (MRSA) was constitutive MLSB (cMLSB) (83%), among methicillin- susceptible S. aureus (MSSA) it was inducible MLSB (iMLSB) (90%). Kanamycin resistance was more frequent than resistance to other aminoglycosides, being 100% for MRSA. Telithromycin was only active against iMLSB, MS and erythromycin- susceptible isolates, although resistance rates were found among iMLSB MSSA (2.78%). Quinupristin/dalfopristin showed greater activity, with resistance rates of 2.5% for MRSA and 1.53% for MSSA. Both vancomycin and linezolid were fully active against all the isolates tested, with the highest MIC value being 2 μg/ml and 4 μg/ml, respectively. Among MRSA strains, 81.67% displayed resistance to five or more antimicrobials. This multiresistance was more frequently found among cMLSB strains (96.38% MRSA resistant to 6-9 agents).

Keywords: linezolid; macrolides; quinupristin/dalfopristin; telithromycin; oxacillin resistance; Staphylococcus aureus

Document Type: Research Article

Publication date: 2004-06-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page